vs
Side-by-side financial comparison of BRUNSWICK CORP (BC) and QuidelOrtho Corp (QDEL). Click either name above to swap in a different company.
BRUNSWICK CORP is the larger business by last-quarter revenue ($1.3B vs $699.9M, roughly 1.9× QuidelOrtho Corp). BRUNSWICK CORP runs the higher net margin — 1.4% vs -104.7%, a 106.1% gap on every dollar of revenue. On growth, BRUNSWICK CORP posted the faster year-over-year revenue change (15.5% vs -3.7%). BRUNSWICK CORP produced more free cash flow last quarter ($83.6M vs $-94.7M). Over the past eight quarters, BRUNSWICK CORP's revenue compounded faster (-1.1% CAGR vs -2.9%).
Brunswick Corporation, formerly known as the Brunswick-Balke-Collender Company, is an American corporation that has been developing, manufacturing and marketing a wide variety of products since 1845. Brunswick has more than 13,000 employees in 24 countries. Brunswick owns a number of brands, including Mercury Marine. In 2024, Brunswick reported sales of US$5.2 billion. Brunswick's global headquarters is in the northern Chicago suburb of Mettawa, Illinois.
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
BC vs QDEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $699.9M |
| Net Profit | $18.7M | $-733.0M |
| Gross Margin | 23.1% | — |
| Operating Margin | 3.1% | -100.7% |
| Net Margin | 1.4% | -104.7% |
| Revenue YoY | 15.5% | -3.7% |
| Net Profit YoY | 122.7% | -3583.4% |
| EPS (diluted) | $0.32 | $-10.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.4B | $699.9M | ||
| Q2 25 | $1.4B | $613.9M | ||
| Q1 25 | $1.2B | $692.8M | ||
| Q4 24 | $1.2B | $707.8M | ||
| Q3 24 | $1.3B | $727.1M | ||
| Q2 24 | $1.4B | $637.0M | ||
| Q1 24 | $1.4B | $711.0M |
| Q4 25 | $18.7M | — | ||
| Q3 25 | $-235.5M | $-733.0M | ||
| Q2 25 | $59.3M | $-255.4M | ||
| Q1 25 | $20.2M | $-12.7M | ||
| Q4 24 | $-82.5M | $-178.4M | ||
| Q3 24 | $44.6M | $-19.9M | ||
| Q2 24 | $100.0M | $-147.7M | ||
| Q1 24 | $68.0M | $-1.7B |
| Q4 25 | 23.1% | — | ||
| Q3 25 | 25.8% | — | ||
| Q2 25 | 25.5% | — | ||
| Q1 25 | 24.9% | — | ||
| Q4 24 | 21.9% | — | ||
| Q3 24 | 26.2% | — | ||
| Q2 24 | 27.1% | — | ||
| Q1 24 | 27.4% | — |
| Q4 25 | 3.1% | — | ||
| Q3 25 | -17.8% | -100.7% | ||
| Q2 25 | 7.1% | -29.4% | ||
| Q1 25 | 4.6% | 4.7% | ||
| Q4 24 | -4.8% | -14.2% | ||
| Q3 24 | 7.7% | 2.1% | ||
| Q2 24 | 11.0% | -18.4% | ||
| Q1 24 | 8.1% | -247.3% |
| Q4 25 | 1.4% | — | ||
| Q3 25 | -17.3% | -104.7% | ||
| Q2 25 | 4.1% | -41.6% | ||
| Q1 25 | 1.7% | -1.8% | ||
| Q4 24 | -7.1% | -25.2% | ||
| Q3 24 | 3.5% | -2.7% | ||
| Q2 24 | 6.9% | -23.2% | ||
| Q1 24 | 5.0% | -239.9% |
| Q4 25 | $0.32 | — | ||
| Q3 25 | $-3.59 | $-10.78 | ||
| Q2 25 | $0.89 | $-3.77 | ||
| Q1 25 | $0.30 | $-0.19 | ||
| Q4 24 | $-1.21 | $-2.54 | ||
| Q3 24 | $0.67 | $-0.30 | ||
| Q2 24 | $1.48 | $-2.20 | ||
| Q1 24 | $0.99 | $-25.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $256.8M | $98.1M |
| Total DebtLower is stronger | $2.1B | $2.5B |
| Stockholders' EquityBook value | $1.6B | $2.0B |
| Total Assets | $5.3B | $5.7B |
| Debt / EquityLower = less leverage | 1.30× | 1.23× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $256.8M | — | ||
| Q3 25 | $297.7M | $98.1M | ||
| Q2 25 | $315.7M | $151.7M | ||
| Q1 25 | $286.7M | $127.1M | ||
| Q4 24 | $269.0M | $98.3M | ||
| Q3 24 | $284.1M | $143.7M | ||
| Q2 24 | $494.5M | $107.0M | ||
| Q1 24 | $548.4M | $78.5M |
| Q4 25 | $2.1B | — | ||
| Q3 25 | — | $2.5B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | $2.4B | $2.1B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B | ||
| Q1 24 | — | $2.2B |
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.6B | $2.0B | ||
| Q2 25 | $1.9B | $2.8B | ||
| Q1 25 | $1.9B | $3.0B | ||
| Q4 24 | $1.9B | $3.0B | ||
| Q3 24 | $2.0B | $3.2B | ||
| Q2 24 | $2.0B | $3.2B | ||
| Q1 24 | $2.0B | $3.3B |
| Q4 25 | $5.3B | — | ||
| Q3 25 | $5.4B | $5.7B | ||
| Q2 25 | $5.8B | $6.4B | ||
| Q1 25 | $5.9B | $6.5B | ||
| Q4 24 | $5.7B | $6.4B | ||
| Q3 24 | $6.0B | $6.8B | ||
| Q2 24 | $6.4B | $6.7B | ||
| Q1 24 | $6.5B | $6.7B |
| Q4 25 | 1.30× | — | ||
| Q3 25 | — | 1.23× | ||
| Q2 25 | — | 0.74× | ||
| Q1 25 | — | 0.70× | ||
| Q4 24 | 1.25× | 0.72× | ||
| Q3 24 | — | 0.68× | ||
| Q2 24 | — | 0.70× | ||
| Q1 24 | — | 0.68× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $132.9M | $-45.5M |
| Free Cash FlowOCF − Capex | $83.6M | $-94.7M |
| FCF MarginFCF / Revenue | 6.3% | -13.5% |
| Capex IntensityCapex / Revenue | 3.7% | 7.0% |
| Cash ConversionOCF / Net Profit | 7.11× | — |
| TTM Free Cash FlowTrailing 4 quarters | $396.3M | $-153.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $132.9M | — | ||
| Q3 25 | $140.4M | $-45.5M | ||
| Q2 25 | $316.2M | $-46.8M | ||
| Q1 25 | $-27.4M | $65.6M | ||
| Q4 24 | $306.4M | $63.7M | ||
| Q3 24 | $67.4M | $117.9M | ||
| Q2 24 | $211.0M | $-97.9M | ||
| Q1 24 | $-153.4M | $-700.0K |
| Q4 25 | $83.6M | — | ||
| Q3 25 | $106.5M | $-94.7M | ||
| Q2 25 | $271.3M | $-84.3M | ||
| Q1 25 | $-65.1M | $9.4M | ||
| Q4 24 | $276.1M | $16.5M | ||
| Q3 24 | $31.4M | $71.4M | ||
| Q2 24 | $163.9M | $-133.2M | ||
| Q1 24 | $-207.4M | $-66.8M |
| Q4 25 | 6.3% | — | ||
| Q3 25 | 7.8% | -13.5% | ||
| Q2 25 | 18.7% | -13.7% | ||
| Q1 25 | -5.3% | 1.4% | ||
| Q4 24 | 23.9% | 2.3% | ||
| Q3 24 | 2.5% | 9.8% | ||
| Q2 24 | 11.4% | -20.9% | ||
| Q1 24 | -15.2% | -9.4% |
| Q4 25 | 3.7% | — | ||
| Q3 25 | 2.5% | 7.0% | ||
| Q2 25 | 3.1% | 6.1% | ||
| Q1 25 | 3.1% | 8.1% | ||
| Q4 24 | 2.6% | 6.7% | ||
| Q3 24 | 2.8% | 6.4% | ||
| Q2 24 | 3.3% | 5.5% | ||
| Q1 24 | 4.0% | 9.3% |
| Q4 25 | 7.11× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 5.33× | — | ||
| Q1 25 | -1.36× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.51× | — | ||
| Q2 24 | 2.11× | — | ||
| Q1 24 | -2.26× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BC
| Engine Partsand Accessories | $532.4M | 40% |
| Navico Group | $452.9M | 34% |
| Recreational Fiberglass Boats | $111.6M | 8% |
| Saltwater Fishing Boats | $85.7M | 6% |
| Controls Riggingand Propellers | $78.3M | 6% |
| Business Acceleration | $48.1M | 4% |
| Sterndrive Engine | $32.6M | 2% |
QDEL
| Labs | $373.8M | 53% |
| Point Of Care | $164.6M | 24% |
| Immunohematology | $142.0M | 20% |
| Donor Screening | $14.7M | 2% |
| Molecular Diagnostics | $4.8M | 1% |
| Collaborative Arrangement Transaction With Party To Collaborative Arrangement | $2.1M | 0% |
